Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rachel Cameron

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Comprehensive Psychiatry|July 16, 2005
Reliability and validity of the work and social adjustment scale in phobic disordersDavid Mataix-Cols, Amy J Cowley, Matthew Hankins, et al.
Hemasphere|July 31, 2023
The MLL-Menin Interaction is a Therapeutic Vulnerability in <i>NUP98</i>-rearranged AMLMilad Rasouli, Helen Blair, Selina Troester, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binderRenee N Brown, Rachel Cameron, David K Chalmers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancerMichael H Kershaw, Jacob T Jackson, Nicole M Haynes, et al.
Virology|July 5, 2003
Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assayCraig J Morton, Rachel Cameron, Lynne J Lawrence, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidaseKeith G Watson, Rachel Cameron, Rob J Fenton, et al.
Journal of Medicinal Chemistry|July 11, 2003
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirusKeith G Watson, Renee N Brown, Rachel Cameron, et al.
Cell Reports|May 10, 2012
A resource for the conditional ablation of microRNAs in the mouseChong Yon Park, Lukas T Jeker, Karen Carver-Moore, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimenSimon J F Macdonald, Keith G Watson, Rachel Cameron, et al.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Comprehensive Psychiatry|July 16, 2005
Reliability and validity of the work and social adjustment scale in phobic disordersDavid Mataix-Cols, Amy J Cowley, Matthew Hankins, et al.
Hemasphere|July 31, 2023
The MLL-Menin Interaction is a Therapeutic Vulnerability in <i>NUP98</i>-rearranged AMLMilad Rasouli, Helen Blair, Selina Troester, et al.
Bioorganic & Medicinal Chemistry Letters|April 6, 2005
2-Ethoxybenzoxazole as a bioisosteric replacement of an ethyl benzoate group in a human rhinovirus (HRV) capsid binderRenee N Brown, Rachel Cameron, David K Chalmers, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 22, 2004
Gene-engineered T cells as a superior adjuvant therapy for metastatic cancerMichael H Kershaw, Jacob T Jackson, Nicole M Haynes, et al.
Virology|July 5, 2003
Structural characterization of respiratory syncytial virus fusion inhibitor escape mutants: homology model of the F protein and a syncytium formation assayCraig J Morton, Rachel Cameron, Lynne J Lawrence, et al.
Bioorganic & Medicinal Chemistry Letters|March 10, 2004
Highly potent and long-acting trimeric and tetrameric inhibitors of influenza virus neuraminidaseKeith G Watson, Rachel Cameron, Rob J Fenton, et al.
Journal of Medicinal Chemistry|July 11, 2003
An orally bioavailable oxime ether capsid binder with potent activity against human rhinovirusKeith G Watson, Renee N Brown, Rachel Cameron, et al.
Cell Reports|May 10, 2012
A resource for the conditional ablation of microRNAs in the mouseChong Yon Park, Lukas T Jeker, Karen Carver-Moore, et al.
Antimicrobial Agents and Chemotherapy|November 25, 2004
Potent and long-acting dimeric inhibitors of influenza virus neuraminidase are effective at a once-weekly dosing regimenSimon J F Macdonald, Keith G Watson, Rachel Cameron, et al.
Journal of Medicinal Chemistry|April 15, 2005
Dimeric zanamivir conjugates with various linking groups are potent, long-lasting inhibitors of influenza neuraminidase including H5N1 avian influenzaSimon J F Macdonald, Rachel Cameron, Derek A Demaine, et al.
Pageof 2